{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:22:29Z","timestamp":1791818549675,"version":"4.3.4"},"reference-count":33,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.205742","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T12:57:42Z","timestamp":1713358662000},"source":"Crossref","is-referenced-by-count":8,"title":["Keratin 6A (KRT6A) promotes radioresistance, invasion, and metastasis in lung cancer via p53 signaling pathway"],"prefix":"10.18632","author":[{"given":"Qiang","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Suzhou Xiangcheng People\u2019s Hospital, Suzhou, Jiangsu, China"},{"name":"Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiteng","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejun","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaofeng","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Suzhou Municipal Hospital affiliated to Nanjing Medical University, Suzhou 215008, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"6","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/CMAR.S149619","article-title":"Gastric cancer: epidemiology, prevention, classification, and treatment.","volume":"1","author":"Polkowski","year":"2018","journal-title":"Cancer Manag Res"},{"key":"3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11912-019-0820-4","article-title":"Updates on Management of Gastric Cancer.","volume":"2","author":"Beckman","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"4","doi-asserted-by":"publisher","first-page":"1010428317714626","DOI":"10.1177\/1010428317714626","article-title":"Progress in the treatment of advanced gastric cancer.","volume":"3","author":"Fang","year":"2017","journal-title":"Tumour Biol"},{"key":"5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.4251\/wjgo.v11.i10.804","article-title":"Precision medicine in gastric cancer.","volume":"1","author":"Buonaguro","year":"2019","journal-title":"World J Gastrointest Oncol"},{"key":"6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000489047","article-title":"Outlook: Immunotherapy in Gastrointestinal Carcinoma - Innovative Strategies.","volume":"4","author":"Lenz","year":"2018","journal-title":"Oncol Res Treat"},{"key":"7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1470-2045(21)00692-6","article-title":"Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.","volume":"2","author":"Kato","year":"2022","journal-title":"Lancet Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12885-021-09118-3","article-title":"Clinical features as potential prognostic factors in patients treated with nivolumab for highly pretreated metastatic gastric cancer: a multicenter retrospective study.","volume":"2","author":"Sakai","year":"2022","journal-title":"BMC Cancer"},{"key":"9","first-page":"361","article-title":"The pelvic mass.","volume":"3","author":"Miyazawa","year":"1988","journal-title":"Patients' ages and pathologic findings. J Reprod Med"},{"key":"10","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/annonc\/mdy264","article-title":"Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.","volume":"2","author":"Lichinitser","year":"2018","journal-title":"Ann Oncol"},{"key":"11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","article-title":"Current Cancer Epidemiology.","volume":"9","author":"Lippi","year":"2019","journal-title":"J Epidemiol Glob Health"},{"key":"12","doi-asserted-by":"publisher","first-page":"e2118457","DOI":"10.1001\/jamanetworkopen.2021.18457","article-title":"Global Incidence and Mortality of Gastric Cancer, 1980-2018.","volume":"4","author":"Liang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"13","doi-asserted-by":"publisher","first-page":"114399","DOI":"10.1016\/j.jep.2021.114399","article-title":"Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.","volume":"27","author":"Ding","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12957-018-1409-3","article-title":"Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.","volume":"1","author":"Li","year":"2018","journal-title":"World J Surg Oncol"},{"key":"15","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.2147\/OTT.S342613","article-title":"Identification and Validation a Necroptosis-related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma.","volume":"1","author":"Liu","year":"2021","journal-title":"Onco Targets Ther"},{"key":"16","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s13277-015-3942-9","article-title":"Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression.","volume":"3","author":"Wang","year":"2016","journal-title":"Tumour Biol"},{"key":"17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S2468-1253(18)30079-7","article-title":"Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.","volume":"3","author":"Marks","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"18","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/j.1440-1746.2005.03842.x","article-title":"Expression of Ep-CAM in intestinal metaplasia, gastric epithelial dysplasia and gastric adenocarcinoma.","volume":"2","author":"Kim","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3390\/cancers12040861","article-title":"Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells.","volume":"1","author":"Oliveira","year":"2020","journal-title":"Cancers (Basel)"},{"key":"20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/mc.20828","article-title":"E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population.","volume":"5","author":"Zhang","year":"2012","journal-title":"Mol Carcinog"},{"key":"21","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1136\/gutjnl-2019-320399","article-title":"Transgenic expression of human PRSS2 exacerbates pancreatitis in mice.","volume":"6","author":"Bi","year":"2020","journal-title":"Gut"},{"key":"22","doi-asserted-by":"publisher","first-page":"1064783","DOI":"10.1155\/2018\/1064783","article-title":"The Polymorphisms atandLoci and the Risk of Post-ERCP Pancreatitis.","volume":"201","author":"Hirankarn","year":"2018","journal-title":"Gastroenterol Res Pract"},{"key":"23","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/genes11111349","article-title":"Role of the CommonHaplotype in Alcoholic and Non-Alcoholic Chronic Pancreatitis: Meta- and Re-Analyses.","volume":"1","author":"Chen","year":"2020","journal-title":"Genes (Basel)"},{"key":"24","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3892\/or_00000812","article-title":"Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.","volume":"2","author":"Ma","year":"2010","journal-title":"Oncol Rep"},{"key":"25","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.1038\/s41388-021-01967-3","article-title":"KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer.","volume":"4","author":"Estanyol","year":"2021","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/0284186X.2020.1733655","article-title":"Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer.","volume":"5","author":"Haglund","year":"2020","journal-title":"Acta Oncol"},{"key":"27","first-page":"435","article-title":"Correlations between serum trypsinogen-2 and pancreatic cancer.","volume":"6","author":"Wang","year":"2015","journal-title":"Hepatogastroenterology"},{"key":"28","doi-asserted-by":"publisher","first-page":"101949","DOI":"10.1016\/j.tice.2022.101949","article-title":"PRSS2 overexpression relates to poor prognosis and promotes proliferation, migration and invasion in gastric cancer.","volume":"7","author":"Wang","year":"2022","journal-title":"Tissue Cell"},{"key":"29","first-page":"1164","article-title":"Invasion and metastasis.","volume":"12","author":"Orr","year":"1983","journal-title":"Can Med Assoc J"},{"key":"30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/00365510151097584","article-title":"Trypsinogen-1, -2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas.","volume":"6","author":"Stenman","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"key":"31","first-page":"10","article-title":"Synthesis and localization of pancreatic secretory proteins in pancreatic acinar-like metaplasia in the distal part of the oesophagus.","volume":"3","author":"Borgstr\u00f6m","year":"2003","journal-title":"Pancreatic acinar metaplasia: another source of pancreatic enzymes! Scand J Gastroenterol"},{"key":"32","first-page":"2967","article-title":"Mutation analysis of the cationic trypsinogen gene in patients with pancreatic cancer.","volume":"2","author":"Boettger","year":"2000","journal-title":"Anticancer Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/(sici)1097-0215(20000515)86:4%3c577::aid-ijc21%3e3.0.co;2-j","article-title":"Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: association with reduced cancer cell migration.","volume":"8","author":"Stenman","year":"2000","journal-title":"Int J Cancer"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T12:57:47Z","timestamp":1713358667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":33,"alternative-id":["205742"],"URL":"https:\/\/doi.org\/10.18632\/aging.205742","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}